Barclays PLC Astrazeneca PLC Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Barclays PLC holds 892,549 shares of AZN stock, worth $69.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

892,549

Previous 660,051 35.22%

Holding current value

$69.6 Million

Previous $44.5 Million 36.03%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $14.2 Million - $16.2 Million	232,498 Added 35.22%	892,549 $60.5 Million
Q4 2023 Feb 15, 2024	SELL	$61.89 - $69.28 $36 Million - $40.3 Million	-582,380 Reduced 46.87%	660,051 $44.5 Million
Q3 2023 Nov 07, 2023	BUY	$64.85 - $71.7 $61.3 Million - $67.7 Million	944,765 Added 317.39%	1,242,431 $84.1 Million
Q2 2023 Aug 03, 2023	SELL	$69.91 - $75.81 $640,515 - $694,571	-9,162 Reduced 2.99%	297,666 $21.3 Million
Q1 2023 May 04, 2023	SELL	$63.15 - $71.6 $2.69 Million - $3.05 Million	-42,633 Reduced 12.2%	306,828 $21.3 Million

Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $12.2 Million - $15.9 Million	225,731 Added 182.44%	349,461 $23.7 Million
Q3 2022 Nov 03, 2022	SELL	$53.02 - $135.75 $5.24 Million - $13.4 Million	-98,798 Reduced 44.4%	123,730 $6.79 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $12.2 Million - $14.6 Million	205,620 Added 1216.11%	222,528 $14.7 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $22.4 Million - $27 Million	-402,616 Reduced 95.97%	16,908 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $21.8 Million - $25.8 Million	404,405 Added 2674.81%	419,524 $24.4 Million
Q3 2021 Nov 09, 2021	SELL	$55.56 - $60.79 $22 Million - $24.1 Million	-396,317 Reduced 96.33%	15,119 $908,000
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $19.9 Million - $24.7 Million	411,027 Added 100495.6%	411,436 $24.6 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $12.5 Million - $14.4 Million	-264,715 Reduced 99.85%	409 $20,000
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $12.8 Million - $15.3 Million	264,077 Added 25222.25%	265,124 $13.3 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $2.1 Million - $2.42 Million	-39,609 Reduced 97.42%	1,047 $58,000
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $2.6 Million - $3.34 Million	-60,357 Reduced 59.75%	40,656 $2.15 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $4.87 Million - $6.62 Million	-128,903 Reduced 56.07%	101,013 $4.51 Million
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $6.29 Million - $7.47 Million	148,058 Added 180.87%	229,916 $11.5 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $35.6 Million - $40.3 Million	-887,375 Reduced 91.55%	81,858 $3.65 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $32.1 Million - $35.9 Million	861,601 Added 800.51%	969,233 $40 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $123,611 - $149,838	-3,483 Reduced 3.13%	107,632 $4.35 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $47,475 - $53,439	1,288 Added 1.17%	111,115 $4.22 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $136,120 - $155,543	3,916 Added 3.7%	109,827 $4.35 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $1.39 Million - $1.49 Million	-40,308 Reduced 27.57%	105,911 $3.72 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $1.51 Million - $1.68 Million	-45,736 Reduced 23.83%	146,219 $5.11 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $339,736 - $368,215	10,587 Added 5.84%	191,955 $6.66 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $5.25 Million - $6.17 Million	181,368	181,368 $6.14 Million

Others Institutions Holding AZN

# of Institutions

1,244

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account